Survey on the treatment and management of tuberculosis patients in China in 2018
Dong-mei HU,Xue LI,Xiao-qiu LIU,Cai-hong XU()
Department of Programme and Planning, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Dong-mei HU,Xue LI,Xiao-qiu LIU,Cai-hong XU. Survey on the treatment and management of tuberculosis patients in China in 2018[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 930-935. doi: 10.3969/j.issn.1000-6621.2019.09.005
World Health Organization. Global tuberculosis report 2018. Geneva:World Health Organization, 2018.
[3]
Wang L, Zhang H, Ruan Y , et al. Tuberculosis prevalence in China,1990—2010:a longitudinal analysis of national survey data. Lancet, 2014,383(9934):2057-2064.
[4]
Van den Boogaard J, Boeree MJ, Kibiki GS , et al. The complexity of the adherence-response relationship in tuberculosis treatment:why are we still in the dark and how can we get out? Trop Med Int Health, 2011,16(6):693-698.
[5]
Liu X, Blaschke T, Thomas B , et al. Usability of a medication event reminder monitor system (MERM) by providers and patients to improve adherence in the management of tuberculosis.Int J Environ Res Public Health, 2017,14(10). pii: E1115.